APA (7th ed.) Citation

F, L., F, W., C, Z., Q, W., T, Z., & YL, Z. (2018). miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker. Dove Medical Press.

Chicago Style (17th ed.) Citation

F, Li, Wang F, Zhu C, Wei Q, Zhang T, and Zhou YL. MiR-221 Suppression Through Nanoparticle-based MiRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker. Dove Medical Press, 2018.

MLA (8th ed.) Citation

F, Li, et al. MiR-221 Suppression Through Nanoparticle-based MiRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker. Dove Medical Press, 2018.